This HTML5 document contains 179 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n11http://dx.doi.org/10.1136/
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34157346
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel tieteellinen artikkeli 2010年论文 2010年论文 2010 nî lūn-bûn научная статья επιστημονικό άρθρο videnskabelig artikel (udgivet 2010) scienca artikolo artigo científico ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ наукова стаття, опублікована у квітні 2010 2010年论文 2010年論文 מאמר מדעי vitenskapelig artikkel научни чланак tudományos cikk artikull shkencor 2010年論文 2010年論文 мақолаи илмӣ artículo científico publicado en 2010 artigo científico (publicado na 2010) мақолаи илмӣ naučni članak vitskapeleg artikkel article scientifique (publié 2010) vedecký článok سائنسی مضمون articolo scientifico 2010年论文 научна статия 2010 թվականի ապրիլին հրատարակված գիտական հոդված 2010年論文 2010年论文 научни чланак 2010年の論文 mokslinis straipsnis article científic artykuł naukowy articol științific 2010年論文 2010년 논문 teaduslik artikkel bilimsel makale wissenschaftlicher Artikel article scientific სამეცნიერო სტატია مقالة علمية vědecký článek artikulong pang-agham vetenskaplig artikel مقالهٔ علمی บทความทางวิทยาศาสตร์ 2010年论文 2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած bài báo khoa học scientific article artículu científicu espublizáu en 2010 artigo científico (publicado na 2010)
p:P577
wds:Q34157346-0FC70F53-FC60-40E6-8694-43CB80441396
wdt:P577
2010-04-01T00:00:00Z
p:P407
wds:Q34157346-9C9D1D3E-821A-4BB3-B8BE-21858820D4D7
wdt:P407
wd:Q1860
p:P2860
wds:Q34157346-FF8ECDFC-06C6-4994-A50D-41D1544FC0C9 wds:Q34157346-EB48F387-F8FD-48C3-B957-571DD898BE54 wds:Q34157346-37F08897-C80A-452F-9D78-8FC581472511 wds:Q34157346-07A00400-82A7-4C77-B38B-002238C4FD14 wds:Q34157346-1079BF90-6566-4890-BCD4-9CC252203A6A wds:Q34157346-019B3260-7E47-4C93-87F6-74479F400100 wds:Q34157346-6D7D3F50-87B3-471B-A592-D9B97B764825 wds:Q34157346-5ACD5721-246F-426D-BCD5-4EEC5F2F2311 wds:Q34157346-4672BA45-BCFA-48AA-9DA8-CBF0F5CB5B5B wds:Q34157346-4CDB0E13-10BB-4E9A-BC70-56D7E81B188D wds:Q34157346-40C813E1-E736-4AB3-B3CD-50E7EB7447A6 wds:Q34157346-9CF0EE60-24C9-4838-8B94-E08193D18984 wds:Q34157346-A4C9F44E-CE7C-4CDD-89CC-B1F965461FD9 wds:Q34157346-8F8D46EC-5A56-49BF-9108-8C74DF64CD33 wds:Q34157346-91F9C657-50BB-4D1A-94B8-D8E0ED60D7EF
wdt:P2860
wd:Q58069337 wd:Q35547478 wd:Q72871584 wd:Q68795043 wd:Q34594335 wd:Q44719227 wd:Q33361908 wd:Q56485907 wd:Q73548256 wd:Q79870371 wd:Q73491900 wd:Q47271726 wd:Q34339837 wd:Q40471593 wd:Q80330583
p:P2093
wds:Q34157346-EEBED4B3-9949-4A1B-8743-CB10AFBE0C81 wds:Q34157346-CD3F207E-4D21-4DB5-8107-555412EF8160 wds:Q34157346-C2FC634A-5946-4838-94D8-29D414EFFED3 wds:Q34157346-DE90560C-386C-4945-AA75-00DC25ABE025 wds:Q34157346-D278B854-94B3-4D97-8144-A3E52248B7A2 wds:Q34157346-947F55AC-69A4-43F7-BCCE-29FBD8BE3BCC wds:Q34157346-A9CF08C8-2401-4A10-81DF-1FC196BAE78D wds:Q34157346-55BC66C1-662C-49E1-96BF-F886F8FA200D wds:Q34157346-7F39CD57-D6F5-4A8C-B69D-9E61F313BCBA wds:Q34157346-526EF240-684F-4F51-A920-39C7114A4511 wds:Q34157346-52B68469-3C31-4939-B256-466C6F7B9165 wds:Q34157346-2AD8B901-1264-4309-BBE5-A6DFC53EF536 wds:Q34157346-3A10F7FA-F29E-4567-824B-93551F6D0F38 wds:Q34157346-00F68AC1-A1E4-42E5-8A7E-D84649FE8C2B wds:Q34157346-00F28C14-FBE4-455A-B505-6DEFF9D26654 wds:Q34157346-10035A75-026F-49DF-9EF7-D38B5B58E82A
wdt:P2093
Yaung-Kaung Shen Stephen Xu Sudha Visvanathan Earl D Silverman Adedigbo Fasanmade Alan Mendelsohn Paediatric Rheumatology INternational Trials Organization (PRINTO) Pediatric Rheumatology Collaborative Study Group (PRCSG) Michael Henrickson Joyce Davidson Nicolino Ruperto Joachim Oppermann Patricia Woo Zsolt Balogh Lisa Imundo Silvia Meiorin
rdfs:label
Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension. Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension. Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension.
skos:prefLabel
Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension. Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension. Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension.
schema:name
Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension. Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension. Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension.
p:P50
wds:Q34157346-16DBFE65-3F94-4202-9598-C4386137CB9B wds:Q34157346-2F262DB1-CC27-46D7-A7AF-87B8B0B5E60C wds:Q34157346-B87EF9B5-B4E6-4E3A-8E46-F81D6D7261DB wds:Q34157346-D2E29827-B2F7-47BA-8444-258DB25A4162 wds:Q34157346-D8F1D73A-2192-44A4-AF95-4AE4E9A47706 wds:Q34157346-42F00731-76B4-4429-8169-AD8CF4378B4A wds:Q34157346-43EC22FC-9A8A-4E32-93FF-F8E8E9633E74
wdt:P50
wd:Q77393750 wd:Q115249013 wd:Q60697163 wd:Q116789190 wd:Q116789192 wd:Q50786009 wd:Q91633712
p:P1476
wds:Q34157346-CBC3B2A9-3495-4558-ADB9-8A03CDE43507
wdt:P1476
Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension
p:P304
wds:Q34157346-FD03A0F5-1956-4235-A70D-E347B3AE473A
wdt:P304
718-722
p:P31
wds:Q34157346-87F20ADA-367E-4623-88E1-970C487C0507
wdt:P31
wd:Q13442814
p:P921
wds:Q34157346-3AC1E233-C3B1-4DC9-A634-0A37004C972A wds:Q34157346-5E1E3CA8-A587-42C7-AAF8-D5C5466CDB9D wds:Q34157346-66CB8F99-A474-436E-9BAC-709348E8EF98
wdt:P921
wd:Q861224 wd:Q422232 wd:Q187255
p:P698
wds:Q34157346-77E342D7-8310-46AC-8276-A965792529BA
wdtn:P698
n10:20237125
wdt:P698
20237125
p:P1433
wds:Q34157346-F7A07709-4C64-4653-8388-E9524BC51AF2
wdt:P1433
wd:Q4767876
p:P433
wds:Q34157346-E12EE107-1A8D-4981-96AE-053CA174DA81
p:P478
wds:Q34157346-BA88E125-F927-4C5E-A772-9ADF44B4B48B
wdt:P433
4
wdt:P478
69
p:P356
wds:Q34157346-1847F5BD-F402-4740-AACF-50DE34989B1F
wdtn:P356
n11:ARD.2009.100354
wdt:P356
10.1136/ARD.2009.100354
p:P5875
wds:Q34157346-384012C9-465C-4BD7-AF60-ADC84DCEADD6
wdt:P5875
42255187
p:P932
wds:Q34157346-1C274E16-299F-4FE6-90D6-AFE2C9296CAE
wdt:P932
2946101